MRK-560

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameMRK-560
Drug Alias NameMRK-560
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPresenilin-1 inhibitors
TargetsPresenilin-1
Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChildrens Cancer Institute
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A